Coats N.P.,Mission Medical, Inc. |
Baranyay J.,Baranyay Consulting Services Corporation
Journal of Cardiovascular Nursing | Year: 2012
Pharmacologic stress myocardial perfusion imaging is a noninvasive method for evaluating coronary artery disease in patients unable to exercise sufficiently to achieve a heart rate high enough to facilitate satisfactory imaging. The nuclear cardiology nurse is an invaluable member of the laboratory team that performs these tests. In this specialist role, the nurse must have a thorough knowledge of the different pharmacologic stress agents (dipyridamole, adenosine, regadenoson, and dobutamine) that can be used. This should comprise an understanding of their mechanisms of action, contraindications, drug-drug interactions, adverse effects, and administration protocols. By drawing on this knowledge, the nurse is able to verify that the right agent has been selected for each patient based on his/her medical history. The nurse also can help patients follow pretest instructions (such as withholding caffeine and certain medications) by explaining that the measures are necessary for a safe and successful procedure and that violation may result in test cancellation or postponement. On the day of the stress test, the nurse has an important role in safeguarding the patient as well as providing support and reassurance throughout the different stages of the examination. Responsibilities include explaining the entire procedure to the patients, notably, what they will be asked to do, the effect of the stress agent, the timing of each step, the adverse effects that they may experience, how any adverse events will be managed, and the importance of remaining still during imaging. This central role of the nuclear cardiology nurse in overseeing the practical aspects of the pharmacologic stress test has important implications in terms of optimizing the productivity and efficiency of their noninvasive cardiology laboratory and nuclear medicine department. © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins.
Tunstall T.D.,Mission Medical, Inc.
Journal of Diagnostic Medical Sonography | Year: 2010
Knowledge of how to prevent healthcare-associated infections within the sonography department is an important step in providing quality care. Employing scientifically based preventative measures will ensure that the tools we use do not become vectors for the spread of pathogens that cause infections. These avoidable infections have not only an added financial cost to patients and the already burdened healthcare system but also physical and emotional costs to the patients we treat. Specific infection control guidelines for the sonography department are lacking, and the guidelines that are available are often based on proven infection control practiced in similar situations. Within this article are the applicable infection guidelines sonographers can use to provide safe quality care. © 2010 The Author(s).
Bitar R.A.,Mission Medical, Inc. |
Bitar R.A.,Pomerado Medical Center
Emerging Infectious Diseases | Year: 2016
Lacking population-specific data, activity of seasonal and pandemic influenza is usually tracked by counting the number of diagnoses and visits to medical facilities above a baseline. This type of data does not address the delivery of services in a specific population. To provide population-specific data, this retrospective study of patients with influenza- like illness, influenza, and pneumonia among members of a Kaiser Permanente health plan in San Diego, California, USA, during October-December 2009 was initiated. Population data included the number of outpatients accessing healthcare; the number of patients diagnosed with pneumonia; antimicrobial therapy administered; number of patients hospitalized with influenza, influenza-like illness, or pneumonia; level of care provided; and number of patients requiring specialized treatments (e.g., oxygen, ventilation, vasopressors). The rate of admissions specific to weeks and predictions of 2 epidemiologic models shows the strengths and weaknesses of those tools. Data collected in this study may improve planning for influenza pandemics. © 2016, Centers for Disease Control and Prevention (CDC). All rights reserved.
Panikulam A.,Mission Medical, Inc.
Indian Journal of Palliative Care | Year: 2011
We CanSupport provide holistic care to the patients and family. This means, physical, emotional, psychosocial and spiritual care. The objective of this article is to implement a plan for improved high quality care, within a dynamic and complex health care system for palliative care. Twelve years of working experience with palliative care in CanSupport ′India′ and 10 years of working palliative care aboard (USA). High level satisfaction of the patient of the patient and families due to the psycho, socio, spiritual model and help for income generation and vocational training. We suggest and encourage, to we this model for all palliative care centre and institutions.
Harms G.,Institute of Tropical Medicine |
Scherbaum H.,Paul Lechler Hospital and Clinic for Tropical Diseases |
Reiter-Owona I.,University of Bonn |
Stich A.,Mission Medical, Inc. |
Richter J.,Heinrich Heine University Dusseldorf
International Journal of Dermatology | Year: 2011
Background Cutaneous leishmaniasis (CL), a parasitic disease which represents a public health problem, particularly in Central and South America, has become a leading condition in travelers who return from tropical countries with skin disorders. Cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis, the most common causative agent, requires systemic treatment because it is potentially able to disseminate and to cause mucosal or mucocutaneous disease. Although several drugs are available for the systemic treatment of leishmaniases, a definitive treatment regimen for infection caused by species of the Viannia subgenus has yet to be established in many countries, including Germany. Methods We analyzed treatment outcomes in 23 returnees from Central and South America who were diagnosed with L.(V.)braziliensis CL by polymerase chain reaction. Results Complete cure within onemonth following treatment was observed in 18 patients (78%). Cure was achieved with liposomal amphotericin B in 11 of 13 patients, miltefosine in five of eight patients, and meglumine antimoniate in two (of two) patients. Of the five patients (22%) who failed to respond to initial therapy, four were cured with meglumine antimoniate and one with liposomal amphotericin B. Conclusions In this outcome evaluation of treatment of imported L.(V.)braziliensis infections, liposomal amphotericin B, miltefosine, and meglumine antimoniate proved to be effective. Conventional meglumine antimoniate showed high efficacy as a first-line treatment and cured lesions that failed to respond to the other two drugs. A multi-country study using standardized treatment protocols is needed to establish a definitive regimen. © 2011 The International Society of Dermatology.